LSZ Impact – Translational Medicine in Zurich

The Life Science Zurich (LSZ) Business Network, together with the Business and Economic Development of the Canton of Zurich, the University of Zurich as well as the Bio-Technopark Schlieren-Zurich organized the first LSZ Impact Conference on Translational Medicine. 300 participants attended the event which took place at the Technopark Zurich on January 22nd 2018, thereof 50% […]

read more

European market-entry strategy for biopharma companies

The European pharmaceutical market offers many opportunities for U.S. biopharmaceutical companies. An early engagement as well as a visceral understanding of the heterogeneity of the European market are key to succeed. Partnering with a Swiss-based, commercial-stage pharmaceutical company offers various advantages. Because of its diversity and non-bureaucratic access to a talented workforce, Switzerland is an […]

read more

Zug goes digital

Zug-based companies from the fields of industry, FinTech and Life Sciences focus on digitalization. Increasing levels of digitalization have led to fundamental transformations and will be a contributing factor in structural changes in many industries. More and more companies operating in the core sectors of industry, FinTech and Life Sciences are going digital; this is […]

read more

Shaping the Future of Bio-IT

Switzerland and particularly the Greater Zurich Area is a leading destination for life sciences and tech companies in Europe. Google, IBM Research, Disney Research, Roche Diagnostics, Biogen, Johnson & Johnson, and other industry leaders are located less than an hour apart from each other. While life sciences continued to grow at a high level in […]

read more

A strongly interlinked med tech network

The canton of Solothurn is Switzerland’s med tech hotspot: Major companies develop and manufacture at the south foot of the Jura Mountains. “We maintain very close business relations with small and medium-sized enterprises here in the canton,” says Thomas Schädler, Vice President of Manufacturing at DePuy Synthes. Küschall AG produces more than 10,000 wheelchairs annually […]

read more

Zurich’s clusters are gaining in importance

Future-oriented clusters such as life sciences, ICT and finance are developing very successfully in the Canton of Zurich. This is revealed in a new study by the Canton of Zurich’s Office for Economy and Labour. The high density of innovative companies and start-ups, world-class research and educational facilities as well as international accessibility all play […]

read more

The Canton of Zug is an International Hotspot for Life Science

The life science sector is one of the most important industries in the Canton of Zug. Many well-known companies like Roche, Novartis, Biogen or Johnson&Johnson have their international headquarter in Zug. The cluster generates many favorable effects like the high availability of talents. Switzerland is one of Europe’s most established life science locations. The country […]

read more

A Battle Fought and Won for the Aerial Cableway – and for Tourism in the Region

Imagine: a highly exclusive club and Solothurn’s landmark mountain right in the middle. The watson online portal recently announced the 13 best lookout points in the country under the title “Where Switzerland is even more beautiful than it already is”. In addition to classics such as Muottas Muragl in Engadine and the panorama trail on […]

read more